Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01871766
Title Treatment of Localized Rhabdomyosarcoma With Chemotherapy, Radiotherapy, and Surgery
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors St. Jude Children's Research Hospital
Indications

rhabdomyosarcoma

Therapies

Bevacizumab + Cyclophosphamide + Sorafenib

Dactinomycin + Vincristine Sulfate

Cyclophosphamide + Dactinomycin + Vincristine Sulfate

Age Groups: adult | child
Covered Countries USA


No variant requirements are available.